Introduction
============

Cerebrovascular disease is one of three major diseases that can threaten human health, among which ischemic cerebrovascular disease accounts for over 80% ([@b1-etm-0-0-4451]). The application of 320-slice volume computed tomography (CT) in whole brain CT perfusion (CTP) imaging can make clear diagnoses in a timely manner during the super acute period (\<6 h) of acute cerebral infarction, evaluate blood perfusion of ischemic brain tissue, and obtain whole brain CT angiography (CTA) and CT venography (CTV) images ([@b2-etm-0-0-4451]). It is a method of hemodynamic evaluation widely applied clinically ([@b3-etm-0-0-4451]) and is important for guiding early clinical treatment, especially for thrombolytic therapy. Reducing the CT scanning radiation dose has been a focus of international studies ([@b4-etm-0-0-4451],[@b5-etm-0-0-4451]). The reduction in tube voltage can reduce the radiation dose patients receive and simultaneously reduce the amount of contrast agent needed to make it more suitable for brain perfusion imaging ([@b6-etm-0-0-4451]). The present study was designed to investigate the application feasibility of the dual low-dose scanning scheme in cerebral infarction whole brain CTP by comparing whole brain CTP image quality and radiation dose of patients with acute cerebral infarction under different tube voltages and contrast agent concentration scanning schemes.

Patients and methods
====================

### Patients

Fifty-nine patients who underwent 320-slice whole brain CTP and diagnosed with acute cerebral infarction in Xuzhou Clinical Medical College from September 2014 to March 2016 were enrolled (excluding those with allergic history to iodinated contrast agent, renal insufficiency and those taking metformin for thyroid disease). The patients included 35 males and 24 females, aged 39--86 years, with mean age of 60.0±14.6 years. The height and weight of all patients were measured before examination and body mass index (BMI) was calculated. Patients were randomly divided into groups A and B and the general parameters are shown in [Table I](#tI-etm-0-0-4451){ref-type="table"}. The present study was approved by the Ethics Committee of Xuzhou Central Hospital and written informed consent was obtained from all the patients.

### Examination methods

An Aquilion 320 volume CT (Toshiba, Ohtawara, Japan) was used for whole brain CTP scanning. For group A, the tube voltage was 100 kV and the contrast agent was iohexol (350 mg I/ml). For group B, the tube voltage was 80 kV and the contrast agent was iodixanol (270 mg I/ml). The other scanning parameters in both groups were the same: The volume scanning mode was used, the thickness was 0.5 mm and the tube current was 310 mA. The proportional total injection volume (50 ml) and flow rate (4 ml/sec) in both groups were the same. The whole brain perfusion scanning scheme was used and the first exposure began 7 sec after contrast agent injection. The exposure time interval was 2 sec during the arterial phase, 4--6 sec during the venous phase, and total scanning time was 62 sec. A total of 19 exposures were achieved at 7, 11, 13, 15, 19, 21, 23, 25, 27, 29, 32, 34, 36, 38, 42, 47, 52, 57 and 62 sec after injection of contrast agent ([Table II](#tII-etm-0-0-4451){ref-type="table"}).

### Reconstruction method

Images from group A were reconstructed with the conventional filtered back projection (FBP) technique and group B with the algebraic reconstruction technique (ART).

### Post-processing of images

A total of 6,080 images divided across 19 groups obtained from scanning were imported to the Toshiba workstation (Toshiba, Tokyo, Japan) and entered into the 4-D perfusion software for analysis (version 3.2; Toshiba). The region of interest (ROI) was selected for CT value measurement in the arterial M1 segment of the brain that the software was used to automatically generate, including other perfusion parameters. CTP referred to repeating multiple scans on the same selected layer continuously during intravenous injection of contrast agent to obtain time-density curves (TDC) (which reflected changes in contrast agent concentrations in organs, and indirectly reflected changes in organ perfusion volume) per pixel on this layer. Cerebral blood flow (CBF), relative cerebral blood volume (rCBV), mean transit time (MTT) and time to peak (TTP) were calculated with different mathematical models based on the curve. These parameters were used to form a new digital matrix. Intuitional and clear parameter color images were obtained through digital-to-analog conversion and pseudo-color processing, named CTP. The Toshiba Aquilion One 320 volume CT (Toshiba) was equipped with a 160-mm range detector (Barui Medical Equipment Co., Beijing, China), which could obtain images of the whole brain under a single exposure, thus whole brain perfusion scanning can be achieved without moving the scanning table. In addition, it can achieve whole brain isotropy, and obtain whole brain horizontal, coronal and sagittal CTP images. Finally, brain CTA and CTV images were obtained through post-processing at the workstation.

All volume data were imported to the Toshiba Vital version 6.5.3 workstation (Toshiba) and whole brain CTA and CTV images were obtained with the digital silhouette technology of the workstation.

### Image quality evaluation

i\) Objective evaluation. CT value at the arterial M1 segment of the brain at the peak in the images of groups A and B were measured and the signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were calculated based on formula ([@b1-etm-0-0-4451]) and formula ([@b2-etm-0-0-4451]): ([@b1-etm-0-0-4451]) SNR = ROI mean CT value/image noise; ([@b2-etm-0-0-4451]) CNR = (ROI mean CT value - mean CT value at the same layer of brain parenchyma)/image noise.

Image noise = standard deviation of the measurement value by CT within the ROI range. Calcification should be avoided to the greatest extent in ROI selections and its area should be over one-half of the lumen area ([Fig. 1A and B](#f1-etm-0-0-4451){ref-type="fig"}).

ii\) Subjective evaluation. Two experienced radiologists independently completed the image quality rating without knowledge of the groupings, and they adopted a 3-level scoring system: A score of 3 indicated excellent image quality with obvious pseudo-color difference, the abnormal perfusion area could be easily identified and the diagnosis was clear; a score of 2 indicated general image quality, relatively obvious pseudo-color difference and the abnormal perfusion area could be identified by adjusting the contrast; a score of 1 indicated poor image quality, blurred pseudo-color difference and the abnormal perfusion area or split layer in the image could not be identified after contrast adjustment. CTP images could not be generated and diagnostic needs were not met ([@b7-etm-0-0-4451]). The consistency of image quality evaluated by the two physicians was assessed by kappa (κ) analysis. κ value, 0.8--1.0 indicated the consistency was excellent; 0.61--0.8 indicated the consistency was better; 0.41--0.6 indicated the consistency was ordinary; and \<0.4 indicated poor consistency.

The matching degree between the abnormal area shown in the images and the symptoms of patients were evaluated, combined with the clinical symptoms of patients according to whole brain CTA and CTP images. The matching degree was evaluated with a 0--2 level scoring system: A score of 2 indicated the CTP hypoperfusion area occurred in the responsible lesion (CBV and CBF were decreased, MTT and TTP were extended), and stenosis or occlusion occurred in the corresponding artery; a score of 1 indicated CTP hypoperfusion occurred in the responsible lesion (CBV and CBF were decreased, MTT and TTP were extended), but no obvious stenosis or occlusion occurred in the corresponding artery, or stenosis of the responsible artery occurred but a CTP low perfusion area was not shown; a score of 0 indicated the symptoms of patients were distinct but CTP and CTA were negative ([@b8-etm-0-0-4451]) ([Figs. 2](#f2-etm-0-0-4451){ref-type="fig"} and [3](#f3-etm-0-0-4451){ref-type="fig"}).

### Effective dose (ED) of radiation and iodine intake

The dose length product (DLP) of all patients was recorded and the ED values were calculated according to formula \[3\]. \[3\] ED = DLP × k; k, conversion factor; in the present study, k = 0.0021 mSv/(mGy·cm). Formula \[4\] was used to calculate the iodine intakes of the patients in both groups. \[4\] Iodine intake = iodine concentration × contrast agent dose.

### The display rate of infarction lesions

The number of patients diagnosed with acute cerebral infarctions were recorded in the two groups and the infarct display rates were compared.

### The adverse reactions of contrast agents

Patients were asked about their comfort within 15--20 min after scanning. Simultaneously, a variety of adverse reactions were recorded within 20 min after scanning and within 3 days during the follow-up period.

### Statistical analysis

SPSS 16.0 statistical software (SPSS, Inc., Chicago, IL, USA) was used for data analysis. Measurement data are expressed as mean ± SD. Comparisons of measurement data between groups were by t-test. Comparisons of subjective image scores and qualitative data were by χ^2^ test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

The general parameters and comparisons of the 59 patients are shown in [Table I](#tI-etm-0-0-4451){ref-type="table"}. The differences in age, gender and BMI between the two groups were not statistically significant (P\>0.05).

The comparison of the CT value, SNR and CNR at the peak of the arterial M1 segment in the brain between groups A and B is shown in [Table III](#tIII-etm-0-0-4451){ref-type="table"}. The differences in CT value, SNR and CNR between the two groups were not statistically significant (P\>0.05).

The evaluations of image quality of groups A and B by the two physicians were consistent (group A, κ value was 0.651, P\<0.001; group B, κ value was 0.760, P\<0.001). The differences in image quality between groups A and B were not statistically significant (physician 1, χ^2^=3.345, P\>0.05; physician 2, χ^2^=1.272, P\>0.05; [Table IV](#tIV-etm-0-0-4451){ref-type="table"}). In the evaluation of matching degree of image display and symptoms, the difference between groups A and B was not statistically significant (P\>0.05) ([Table V](#tV-etm-0-0-4451){ref-type="table"} and [Figs. 2](#f2-etm-0-0-4451){ref-type="fig"} and [3](#f3-etm-0-0-4451){ref-type="fig"}).

DLP, ED, contrast agent dose and iodine intake in groups A and B are shown in [Table VI](#tVI-etm-0-0-4451){ref-type="table"}. The ED decreased by 5.48 mSv (45%) in group B compared with group A. Iodine intake in group B was reduced by 4,000 mg (23%) compared with groups A ([Table VI](#tVI-etm-0-0-4451){ref-type="table"}).

Among 28 patients in group A, there were eight without acute infarct, 15 with one infarct, and five with two infarcts. Among 31 patients in group B, there were nine diagnosed without acute infarct, 18 with one infarct, three with two infarcts and one with three infarcts. The results showed that the rate of diagnosis of infarcts was not statistically significant between groups A and B (χ^2^=1.683, P\>0.05) ([Table VII](#tVII-etm-0-0-4451){ref-type="table"}).

The 59 patients were without extravasation of contrast agent during scanning. There were no significant allergic reactions within 15--20 min after scanning. Within 3 days during the follow-up period, four patients had moderate allergic reactions \[two patients in group A (2/28, 7.1%), two patients in group B (2/31, 6.5%)\]. Two patients manifested with facial rash and swelling (one patients in each group), one patient manifested abdominal urticaria (group A) and one with vomiting (group B).

Discussion
==========

The 320-slice whole brain CTP is a form of 'one-stop' CT examination for hyperacute cerebral infarction that includes the joint application of routine CTP, CTA and CTV. Some refer to it as a multi-mode CT examination ([@b9-etm-0-0-4451]). However, because multiple perfusion images require continuous exposure, subjects will suffer from higher radiation doses. In recent years, reducing the radiation dose has been a focus of international research ([@b10-etm-0-0-4451]--[@b12-etm-0-0-4451]). Recent studies ([@b13-etm-0-0-4451]--[@b15-etm-0-0-4451]) show that low kV scanning can cause average X-ray photon energy closer to the iodine K-edge and decrease Compton scattering, so that CT values will be increased, while radiation doses will be reduced.

With increasing application of contrast agents, the incidence of contrast-induced nephropathy (CIN) has significantly increased. According to a previous study, in addition to the osmotic pressure factor, the viscosity of contrast agents are a key factor in determining the incidence of CIN ([@b16-etm-0-0-4451]). Therefore, it is worth investigating how the isotonic contrast agent, iodixanol can be modified by reducing its viscosity to make it closer to physiological characteristics, while maintaining its isotonic characteristics. According to the isotonic iodine effect, the dose of contrast agent must be increased to make 270 mg I/ml iodixanol reach the development effect of 350 mg I/ml iohexol, and the latter increase will lead to increased risk of CIN ([@b17-etm-0-0-4451]). In the present study, it was shown that the low kV scheme (group B) X-ray output energy was closer to the 33 keV iodine K-edge, and no decrease in intracranial CT value was observed by comparing different kV scanning schemes between the two groups.

With the progress of technology, ART is increasingly applied in the CT reconstruction scheme. The latest ART reconstruction can not only effectively reduce the image noise and improve image SNR and CNR, thus maintaining or even improving the image quality, but can also make up for the crease in image noise and decrease in image quality from low kV, thereby reducing the ED ([@b17-etm-0-0-4451]).

The results of the present study showed that the differences in CT value, SNR, CNR, CTP and CTA subjective image quality evaluations between group B (iodixanol, 270 mg I/ml) and 80 kV scanning scheme combined with ART reconstruction) and group A (iohexol, 350 mg I/ml) and 100 kV scanning scheme combined with FBP reconstruction) were not statistically significant (P\>0.05). All imaging modalities met the needs of clinical diagnosis; there was no significant difference in the capacity of finding acute infarcts between the groups (P\>0.05); the ED and iodine intake in group B (dual low-dose group) were significantly lower than in group A. Therefore, the application of dual low-dose scanning scheme combined with iterative reconstruction techniques can reduce ED suffered by patients, reduce intake of iodine, meet the needs of clinical diagnosis and minimize possible side effects.

The limitations of the present study were: i) The partial artery lumens in the brain were small, ROI selection generated artifacts easily because of the partial volume effect; ii) the sample size was small. Large sample sizes are required for further confirmation; and iii) in evaluating patients with intracranial arterial stenosis, the comparison was not made with the gold standard (DSA) control, therefore its diagnostic accuracy of stenosis could not be evaluated.

![The objective evaluation of the image quality. (A) A 71-year-old male presented with sudden dizziness for no obvious cause 2 h before evaluation, accompanied with salivation. The figure shows the horizontal axis surface at the arterial M1 segment of the brain of a representative patient in group A. Tube voltage, 100 kV; contrast agent, iohexol (350 mg I/ml), reconstructed with FBP. An area of 2 mm^2^ was selected as the ROI, and the CT value at the arterial M1 segment in the left brain was measured as 498.9 HU±30.8 and the CT value of the brain parenchyma on the same layer was 49.3 HU±30.8. (B) A 59-year-old male presented with sudden double vision, accompanied with dizziness and headache. The figure shows the horizontal axis surface at the arterial M1 segment of the brain of a representative patient in group B. Tube voltage, 80 kV; contrast agent, iodixanol (270 mg I/ml), reconstructed with algebraic reconstruction technique. An area of 2 mm^2^ was selected as the ROI, and the CT value at the arterial M1 segment in the left brain was measured as 474.7 HU±20.6 and the CT value of the brain parenchyma on the same layer was 38.6 HU±8.7. FBP, filtered back projection; ROI, region of interest; CT, computed tomography.](etm-14-01-0163-g00){#f1-etm-0-0-4451}

![A 55-year-old male presented with slurred speech, accompanied with right limb weakness for 3 h. The scanning scheme in group A (100 kV, 350 mg I/ml iohexol, reconstructed by FBP) was used. The subjective image quality score by two physicians was 3; the clinical symptoms were positive, CTP and CTA were consistent with the clinical symptoms, the matching rate score of the clinical symptoms and imaging diagnosis rate was 2. (A) The cerebral perfusion CBV image shows that the CBV of the frontotemporal parietal lobes on both sides were basically symmetrical. (B) The cerebral perfusion CBF image shows that CBF of the frontotemporal parietal lobes on both sides were substantially symmetrical. (C) The cerebral perfusion MTT image shows the left frontotemporal lobe MTT was extended (compared with the opposite side, there was a large area of red time extension on the left frontotemporal lobe and the time was short to the extent of long pseudo-color change: Blue → green → yellow → red). (D) The cerebral perfusion TTP image shows the left frontotemporal lobe TTP was extended (there was a large area of red and yellow time extension area on the left frontotemporal lobe). (E) CTA image shows there was a distal occlusion (arrow) at arterial M1 segment of the left brain. FBP, filtered back projection; CTP, computed tomography perfusion; CTA, CT angiography; MTT, mean transit time.](etm-14-01-0163-g01){#f2-etm-0-0-4451}

![A 50-year-old male, presented with dizziness, accompanied with nausea for no obvious cause 2.5 h before examination. Group B (80 kV, 270 mg I/ml iodixanol, reconstructed by ART). The subjective image quality score by the two physicians was 2; the clinical symptoms were positive, CTP was positive, CTA was negative and the matching degree score of the clinical symptoms and imaging diagnosis was 1. (A) The CBV image shows the CBVs of the frontotemporal parietal lobe on both sides were basically symmetrical. (B) The CBF image shows the CBFs of the frontotemporal parietal lobe on both sides were substantially symmetrical. (C) The cerebral perfusion MTT image shows the MTT of the frontotemporal lobes on both side was substantially symmetrical (D) The cerebral perfusion transit TTP image shows the right frontotemporal lobe TTP was extended compared with the left (there was partial green time extension area on the right frontotemporal lobe relative to the left original blue zone). (E) CTA image shows there was no significant arterial stenosis in the brain. ART, algebraic reconstruction technique; CTP, computed tomography perfusion; CTA, CT angiography; CBV, cerebral blood volume; CBF, cerebral blood flow; MTT, mean transit time; TTP, time to peak.](etm-14-01-0163-g02){#f3-etm-0-0-4451}

###### 

Basic parameters of patients in groups A and B.

  Groups    Case no. (male/female)   Age (years)   BMI (kg/m^2^)
  --------- ------------------------ ------------- ---------------
  Group A   28 (18/10)               61.8±11.7     24.2±3.6
  Group B   31 (17/14)               58.3±16.8     24.2±3.3
  P-value   0.648                    0.942         0.984

BMI, body mass index.

###### 

Scanning schemes in groups A and B.

                           Tube voltage (kV)   Tube current (mA)   Exposure time (sec) (time after injection of contrast agent)   Exposure time interval (sec)                        
  ------------------------ ------------------- ------------------- -------------------------------------------------------------- ------------------------------ ------- ------- ---- ----
  1 ([@b1-etm-0-0-4451])   100                 80                  310                                                            310                            7       7       --   --
  2 ([@b3-etm-0-0-4451])   100                 80                  150                                                            150                            11-15   11-15   2    2
  3 ([@b6-etm-0-0-4451])   100                 80                  310                                                            310                            19-29   19-29   2    2
  4 ([@b4-etm-0-0-4451])   100                 80                  150                                                            150                            32-38   32-38   2    2
  5 ([@b5-etm-0-0-4451])   100                 80                  310                                                            310                            47-62   47-62   5    5

###### 

Comparison of CT value, SNR and CNR at arterial M1 segment of the brain between groups A and B (mean ± SD).

                  Total value   BMI \<23 kg/m^2^ subgroup   BMI ≥23 kg/m^2^ subgroup                                                                   
  --------------- ------------- --------------------------- -------------------------- ------------- ------------- ------- ------------- ------------- -------
  CT value (HU)   495.7±125.4   496.0±125.2                 0.993                      548.5±125.6   512.9±145.2   0.550   466.4±118.6   485.3±113.6   0.623
  SNR             20.9±11.5     17.9±7.8                    0.234                      21.3±10.2     16.3±6.8      0.178   20.7±12.4     18.9±8.3      0.609
  CNR             18.7±10.3     15.8±7.0                    0.209                      19.4±4.5      14.4±6.2      0.156   18.4±10.9     16.7±7.6      0.600

CT, computed tomography; SNR, signal-to-noise ratio; CNR, contrast-to-noise ratio; BMI, body mass index.

###### 

CTP image quality scores and comparison between groups A and B by two physicians.

                Group A   Group B                              
  ------------- --------- --------- ---- --- ---- ---- ------- -------
  Physician 1   1         11        16   0   7    24   3.345   0.188
  Physician 2   1         10        17   0   10   21   1.272   0.529

Group A, κ=0.651, P\<0.001; group B, κ=0.760, P\<0.001. CTP, computed tomography perfusion.

###### 

Matching degree score and comparison of the image display and symptoms between groups A and B.

  Groups    Score 2   Score 1   Score 0
  --------- --------- --------- ---------
  Group A   11        6         11
  Group B   13        9         9

χ^2^=0.816, P=0.665.

###### 

Comparison of indicators between groups A and B.

  Indicator                  Group A    Group B
  -------------------------- ---------- ----------
  Tube voltage (kV)          100        80
  DLP (mGy·cm)               5,743.50   3,131.10
  ED (mSv)                   12.06      6.58
  Contrast agent dose (ml)   50         50
  Iodine intake (mg)         17,500     13,500

DLP, dose length product; ED, effective dose.

###### 

Comparison of diagnosis rate of acute infarct between groups A and B.

                   Group A   Group B                        
  ---------------- --------- --------- --- --- --- ---- --- ---
  No. of lesions   8         15        5   0   9   18   3   1

χ^2^=1.683, P=0.641.
